| First Author | Ma D | Year | 2017 |
| Journal | Biochem Biophys Res Commun | Volume | 482 |
| Issue | 2 | Pages | 366-374 |
| PubMed ID | 27856242 | Mgi Jnum | J:241148 |
| Mgi Id | MGI:5897922 | Doi | 10.1016/j.bbrc.2016.11.069 |
| Citation | Ma D, et al. (2017) 1, 25(OH)2D3-induced interaction of vitamin D receptor with p50 subunit of NF-kappaB suppresses the interaction between KLF5 and p50, contributing to inhibition of LPS-induced macrophage proliferation. Biochem Biophys Res Commun 482(2):366-374 |
| abstractText | KLF5 and nuclear factor kappaB (NF-kappaB) regulate cell proliferation and inflammation. Vitamin D signaling through vitamin D receptor (VDR) exerts anti-proliferative and anti-inflammatory actions. However, an actual relationship between KLF5, NF-kappaB and VDR in the inflammation and proliferation of macrophages is still unclear. Here, we showed that LPS and proinflammatory cytokines stimulate KLF5 gene expression in macrophages, and that 1, 25(OH)2D3 suppresses LPS-induced KLF5 expression and cell proliferation via upregulation of VDR expression. Mechanistic studies suggested that KLF5 interacts with p50 subunit of NF-kappaB to cooperatively induce the expressions of positive cell cycle regulators cyclin B1 and Cdk1/Cdc2 in LPS-treated macrophages. Further studies revealed that 1, 25(OH)2D3-induced interaction of VDR with p50 decreases LPS-induced interaction of KLF5 with p50. Collectively, we identify a novel regulatory pathway in which 1, 25(OH)2D3 induces VDR expression and promotes VDR interaction with p50 subunit of NF-kappaB, which in turn attenuates the association of KLF5 with p50 subunit of NF-kappaB and thus exerts anti-inflammatory and anti-proliferative effects on macrophages. |
